No price history available.
Key financial summary
Financials in MYR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | MYRm | 2,362 | 2,627 | 2,921 | 3,419 | 3,922 | 4,258 | N/A | N/A |
| Operating profit | MYRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | MYRm | 110 | 51 | 167 | 263 | 354 | 366 | N/A | N/A |
| EPS reported | MYR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | MYR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | MYR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | MYR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | MYRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | MYRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | MYRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | MYR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | MYR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in MYR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
KPJ Healthcare Berhad functions as an investment holding company, primarily engaged in the management and operation of an extensive network of specialized hospitals both within Malaysia and across international markets including Indonesia, Thailand, and Bangladesh. Beyond its core hospital services, the company offers a comprehensive array of healthcare and support provisions. These include advanced pathology and laboratory diagnostics, specialized ophthalmic medical and consultancy services, and essential maintenance for both hospital facilities and medical equipment. Its diverse portfolio also spans the operation of various care centers such as polyclinics, dialysis units, facilities for aged care, assisted living, post-natal recovery, and rehabilitation, alongside developing and managing retirement village complexes and ambulatory care centers. KPJ further contributes to healthcare education through its private university college for nursing and allied health professions. The company's commercial activities extend to retail pharmacies, the distribution and marketing of medical, pharmaceutical, and consumer healthcare products, and providing information technology solutions encompassing healthcare information systems and human resource management software rentals. Additionally, KPJ provides internal operational support services like human resource management, building maintenance, sterile processing, laundry, central kitchen operations, and training. Geographically, in addition to its hospital footprint, KPJ operates senior and assisted living care facilities in both Malaysia and Australia. The company was founded in Kuala Lumpur, Malaysia, in 1981, where its headquarters are located.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
KPJ Healthcare Berhad functions as an investment holding company, primarily engaged in the management and operation of an extensive network of specialized hospitals both within Malaysia and across international markets including Indonesia, Thailand, and Bangladesh. Beyond its core hospital services, the company offers a comprehensive array of healthcare and support provisions. These include advanced pathology and laboratory diagnostics, specialized ophthalmic medical and consultancy services, and essential maintenance for both hospital facilities and medical equipment. Its diverse portfolio also spans the operation of various care centers such as polyclinics, dialysis units, facilities for aged care, assisted living, post-natal recovery, and rehabilitation, alongside developing and managing retirement village complexes and ambulatory care centers. KPJ further contributes to healthcare education through its private university college for nursing and allied health professions. The company's commercial activities extend to retail pharmacies, the distribution and marketing of medical, pharmaceutical, and consumer healthcare products, and providing information technology solutions encompassing healthcare information systems and human resource management software rentals. Additionally, KPJ provides internal operational support services like human resource management, building maintenance, sterile processing, laundry, central kitchen operations, and training. Geographically, in addition to its hospital footprint, KPJ operates senior and assisted living care facilities in both Malaysia and Australia. The company was founded in Kuala Lumpur, Malaysia, in 1981, where its headquarters are located.